Allison Transmission reports Q1 2026 results on May 4, and the clearest tension heading in is simple: the stock has run hard while Wall Street's consensus has barely moved.
Options positioning has tilted marginally more defensive into the print. The put/call ratio is running at 0.84, about 1.5 standard deviations above its 20-day mean of 0.76 — not an extreme reading, but a measurable shift toward protection relative to recent norms. The stock closed at $134.35 on April 30, up 4% on the day but down slightly on the week. More striking is the one-month gain: ALSN has rallied 19%, well above most of its peers heading into the same macro environment. Close correlated names WAB and PCAR gave back ground over the past week, falling 0% and 6% respectively, while ALSN held closer to flat.
The short-seller footprint is not the story here. Short interest runs at roughly 3.1% of free float — modest — though the position has grown about 30% over the past month, nudging higher as the stock climbed. Borrow remains essentially free at 0.37% annualised cost, down nearly 20% on the week, and availability is extremely loose. That combination describes a market where shorts are building quietly but face no structural pressure: no squeeze dynamic, no crowding.
The real debate sits at the analyst level, and it's one of calibration rather than conviction. The Street's average price target of $133.30 is effectively in line with the current price — there is almost no implied upside priced into the consensus. Citigroup raised its target to $135 in mid-April while staying Neutral. Morgan Stanley and Wells Fargo both lifted targets earlier in the year but remain at Equal-Weight. The direction of travel has been unambiguously upward — targets have been revised up repeatedly since January — yet no major firm has moved off the sidelines. The EV/EBITDA multiple has been compressing, down about 0.16 turns over the past month to 7.9x, even as the absolute price rose. That compression suggests earnings have been running ahead of what the price would imply, which makes the Q1 number itself the next test of whether that gap can be sustained.
On the factor side, ALSN's dividend score ranks in the 92nd percentile, and estimated forward EPS growth year-on-year ranks in the 72nd percentile — both constructive. But near-term EPS momentum has faded, with the 30-day reading in just the 21st percentile. That divergence — strong structural earnings growth, softening near-term estimate momentum — frames exactly what the Q1 print will be asked to resolve: whether the company can deliver numbers that justify a stock that has re-rated sharply higher while the consensus has stood still.
See the live data behind this article on ORTEX.
Open ALSN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
